HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Supplement Industry Sees Encouragement From Federal Research Agency, Caution From Regulator

Latest NIH AREDS2 Results Strong; FDA Launches ‘Benefit And Risk’ Information Initiative

Executive Summary

FDA launches initiative to advise health care professionals and consumers about potential benefits and risks associated with supplements; NIH announces latest strong results from ongoing AREDS study; and Walmart recalls drug-spiked supplement agency initially identified as adulterated in January.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152592

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel